The role of novel drugs in multiple myeloma

Enrique M. Ocio, Paul G. Richardson, S. Vincent Rajkumar, Antonio Palumbo, María‐Victoria Mateos, Robert Z. Orlowski, Shaji Kumar, Saad Z. Usmani, David Roodman, Rubén Niesvizky, Hermann Einsele, Kenneth C. Anderson, Meletios A Dimopoulos, Hervé Avet‐Loiseau, U-H Mellqvist, Ingemar Turesson,

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1093/annonc/mdn444
Year: 2008
Published: —
Language: en

Article Details

Volume: 19
Link Of The Paper: https://doi.org/10.1093/annonc/mdn444

Timeline

Created:June 19, 2026

Giampaolo Merlini,

Rik Schots,

Philip L. McCarthy,

Leif Bergsagel,

Chor Sang Chim,

Juan José Lahuerta,

Jatin J. Shah,

Tony Reiman,

Joseph Mıkhael,

Sonja Zweegman,

Sagar Lonial,

Ray Comenzo,

Wee Joo Chng,

Philippe Moreau,

Pieter Sonneveld,

Heinz Ludwig,

B G M Durie,

Jesús F. San Miguel

Letter2018

Managing myeloma with limited resources in the era of novel drugs

Meletios A Dimopoulos, Efstathios Kastritis

Article2009

Multiple Myeloma in the Era of Novel Agents

Meletios A Dimopoulos, Michel Attal

Article2005

Novel treatments of multiple myeloma

Meletios A Dimopoulos, Αchilles Anagnostopoulos, Evangelos Terpos

Article2010

Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents

Μαρία Ρούσσου, Efstathios Kastritis, Dimitrios Christoulas, Magdalini Migkou, Maria Gavriatopoulou, Irini Grapsa, Erasmia Psimenou, Dimitra Gika, Evangelos Terpos, Meletios A Dimopoulos